Cash and equivalents
Balance – as of period end · $M
Q3 2021
1,653$M
All values (42)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 710 | reported |
| Q1 2026 | 886 | reported |
| Q4 2025 | 1,165 | reported |
| Q3 2025 | 894 | reported |
| Q2 2025 | 3,206 | reported |
| Q1 2025 | 1,564 | reported |
| Q4 2024 | 2,102 | reported |
| Q3 2024 | 1,404 | reported |
| Q2 2024 | 1,381 | reported |
| Q1 2024 | 1,512 | reported |
| Q4 2023 | 1,705 | reported |
| Q3 2023 | 910 | reported |
| Q2 2023 | 710 | reported |
| Q1 2023 | 1,022 | reported |
| Q4 2022 | 1,325 | reported |
| Q3 2022 | 822 | reported |
| Q2 2022 | 717 | reported |
| Q1 2022 | 878 | reported |
| Q4 2021 | 1,874 | reported |
| Q3 2021 | 1,653 | reported |
| Q2 2021 | 1,921 | reported |
| Q1 2021 | 1,320 | reported |
| Q4 2020 | 1,254 | reported |
| Q3 2020 | 1,007 | reported |
| Q2 2020 | 1,341 | reported |
| Q1 2020 | 1,672 | reported |
| Q4 2019 | 1,001 | reported |
| Q3 2019 | 1,138 | reported |
| Q2 2019 | 953 | reported |
| Q1 2019 | 886 | reported |
| Q4 2018 | 1,257 | reported |
| Q3 2018 | 839 | reported |
| Q2 2018 | 878 | reported |
| Q1 2018 | 795 | reported |
| Q4 2017 | 1,205 | reported |
| Q3 2017 | 653 | reported |
| Q2 2017 | 742 | reported |
| Q1 2017 | 766 | reported |
| Q4 2016 | 967 | reported |
| Q3 2016 | 1,687 | reported |
| Q2 2016 | 1,545 | reported |
| Q1 2016 | 1,940 | reported |
CSV with all sources · Technical ID: cash
More metrics for Motorola Solutions
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Operating income by segment
Gross profit by segment
Sources & calculation
- Value
- $1.7B
- Period
- Q3 2021, ended Oct 2, 2021 · as of Oct 2, 2021 (balance as of date, not a sum)
- Source
- 10-Q, filed Nov 4, 2021 · 0000068505-21-000027
- Location
- us-gaap:CashAndCashEquivalentsAtCarryingValue
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $1.7B | Nov 4, 2021 | 10-Q 0000068505-21-000027 | reported · confidence 1. · current |